ID

41144

Description

Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT01139203

Lien

https://clinicaltrials.gov/show/NCT01139203

Mots-clés

Versions (1)
  1. 30/06/2020 30/06/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

30 juin 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Liver Transplantation NCT01139203

Anglais

Eligibility Liver Transplantation NCT01139203

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients into the transplant waiting list with hbv-related liver disease.
Description

Patients Transplant Waiting List | Liver disease Hepatitis B virus Related

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C3272315
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0019169
UMLS CUI [2,3]
C0439849
2. hbsag-positive.
Description

Hepatitis B surface antigen positive

Type de données

boolean

Alias
UMLS CUI [1]
C0149709
3. serum hbv-dna negative.
Description

Hepatitis B DNA assay negative

Type de données

boolean

Alias
UMLS CUI [1]
C1168041
4. no hcv, hdv and hiv co-infection.
Description

HCV coinfection Absent | HDV Coinfection Absent | HIV coinfection Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1698259
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0011220
UMLS CUI [2,2]
C0275524
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C4062778
UMLS CUI [3,2]
C0332197
5. without renal dysfunction.
Description

Renal dysfunction Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C3279454
UMLS CUI [1,2]
C0332197
6. no lamivudine, adefovir and entecavir drug allergy history.
Description

Hypersensitivity Absent Lamivudine | Hypersensitivity Absent Adefovir | Hypersensitivity Absent Entecavir

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0209738
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0050175
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0971023
7. no hbv-ymdd mutation for patients who have a long-term use of lamivudine.
Description

Hepatitis B virus YMDD mutation Absent | Lamivudine Use Long-term

Type de données

boolean

Alias
UMLS CUI [1,1]
C1714485
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0209738
UMLS CUI [2,2]
C0457083
UMLS CUI [2,3]
C0443252
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with hbv-related hepatocellular carcinoma beyond milan criteria.
Description

Liver carcinoma Hepatitis B virus Related

Type de données

boolean

Alias
UMLS CUI [1,1]
C2239176
UMLS CUI [1,2]
C0019169
UMLS CUI [1,3]
C0439849
2. hbsag-negative.
Description

Hepatitis B surface antigen negative

Type de données

boolean

Alias
UMLS CUI [1]
C0919711
3. serum hbv-dna positive.
Description

Hepatitis B DNA Positive

Type de données

boolean

Alias
UMLS CUI [1]
C5206277
4. hcv, hdv and hiv co-infection.
Description

HCV coinfection | HDV Coinfection | HIV coinfection

Type de données

boolean

Alias
UMLS CUI [1]
C1698259
UMLS CUI [2,1]
C0011220
UMLS CUI [2,2]
C0275524
UMLS CUI [3]
C4062778
5. patients with severe renal dysfunction or failure.
Description

Renal dysfunction Severe | Kidney Failure Severe

Type de données

boolean

Alias
UMLS CUI [1,1]
C3279454
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0035078
UMLS CUI [2,2]
C0205082
6. lamivudine, adefovir and entecavir drug allergy history.
Description

Hypersensitivity Lamivudine | Hypersensitivity Adefovir | Hypersensitivity Entecavir

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0209738
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0050175
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0971023
7. hbv-ymdd mutation for patients who have a long-term use of lamivudine.
Description

Hepatitis B virus YMDD mutation | Lamivudine Use Long-term

Type de données

boolean

Alias
UMLS CUI [1]
C1714485
UMLS CUI [2,1]
C0209738
UMLS CUI [2,2]
C0457083
UMLS CUI [2,3]
C0443252
Retour au début de la page

Similar models

Eligibility Liver Transplantation NCT01139203

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Patients Transplant Waiting List | Liver disease Hepatitis B virus Related
Item
1. patients into the transplant waiting list with hbv-related liver disease.
boolean
C0030705 (UMLS CUI [1,1])
C3272315 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0019169 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
Hepatitis B surface antigen positive
Item
2. hbsag-positive.
boolean
C0149709 (UMLS CUI [1])
Hepatitis B DNA assay negative
Item
3. serum hbv-dna negative.
boolean
C1168041 (UMLS CUI [1])
HCV coinfection Absent | HDV Coinfection Absent | HIV coinfection Absent
Item
4. no hcv, hdv and hiv co-infection.
boolean
C1698259 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C4062778 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Renal dysfunction Absent
Item
5. without renal dysfunction.
boolean
C3279454 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Hypersensitivity Absent Lamivudine | Hypersensitivity Absent Adefovir | Hypersensitivity Absent Entecavir
Item
6. no lamivudine, adefovir and entecavir drug allergy history.
boolean
C0020517 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0209738 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0050175 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0971023 (UMLS CUI [3,3])
Hepatitis B virus YMDD mutation Absent | Lamivudine Use Long-term
Item
7. no hbv-ymdd mutation for patients who have a long-term use of lamivudine.
boolean
C1714485 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0209738 (UMLS CUI [2,1])
C0457083 (UMLS CUI [2,2])
C0443252 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Liver carcinoma Hepatitis B virus Related
Item
1. patients with hbv-related hepatocellular carcinoma beyond milan criteria.
boolean
C2239176 (UMLS CUI [1,1])
C0019169 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
Hepatitis B surface antigen negative
Item
2. hbsag-negative.
boolean
C0919711 (UMLS CUI [1])
Hepatitis B DNA Positive
Item
3. serum hbv-dna positive.
boolean
C5206277 (UMLS CUI [1])
HCV coinfection | HDV Coinfection | HIV coinfection
Item
4. hcv, hdv and hiv co-infection.
boolean
C1698259 (UMLS CUI [1])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Renal dysfunction Severe | Kidney Failure Severe
Item
5. patients with severe renal dysfunction or failure.
boolean
C3279454 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0035078 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Hypersensitivity Lamivudine | Hypersensitivity Adefovir | Hypersensitivity Entecavir
Item
6. lamivudine, adefovir and entecavir drug allergy history.
boolean
C0020517 (UMLS CUI [1,1])
C0209738 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0050175 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0971023 (UMLS CUI [3,2])
Hepatitis B virus YMDD mutation | Lamivudine Use Long-term
Item
7. hbv-ymdd mutation for patients who have a long-term use of lamivudine.
boolean
C1714485 (UMLS CUI [1])
C0209738 (UMLS CUI [2,1])
C0457083 (UMLS CUI [2,2])
C0443252 (UMLS CUI [2,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial